Literature DB >> 25388061

A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.

Yuhree Kim1, Gaya Spolverato, Aslam Ejaz, Malcolm H Squires, George Poultsides, Ryan C Fields, Mark Bloomston, Sharon M Weber, Konstantinos Votanopoulos, Alexandra W Acher, Linda X Jin, William G Hawkins, Carl Schmidt, David Kooby, David Worhunsky, Neil Saunders, Edward A Levine, Clifford S Cho, Shishir K Maithel, Timothy M Pawlik.   

Abstract

BACKGROUND: The American Cancer Society projects there will be over 22,000 new cases, resulting in nearly 11,000 deaths, related to gastric adenocarcinoma in the US in 2014. The aim of the current study was to find clinicopathologic variables associated with disease-free survival (DFS) and overall survival (OS) following curative resection of gastric adenocarcinoma, and create a nomogram for individual risk prediction.
METHODS: A nomogram to predict DFS and OS following surgical resection of gastric adenocarcinoma was constructed using a multi-institutional cohort of patients who underwent surgery for primary gastric adenocarcinoma at seven major institutions in the US between January 2000 and August 2013. Discrimination and calibration of the nomogram were tested by C-statistic, Kaplan-Meier curves, and calibration plots.
RESULTS: A total of 719 patients who underwent surgery for primary gastric adenocarcinoma were included in the study. Using the backward selection of clinically relevant variables with Akaike information criteria, age, sex, tumor site, depth of invasion, and lymph node ratio (LNR) were selected as factors predictive of OS, while age, tumor site, depth of invasion, and LNR were incorporated in the prediction of DFS. A nomogram was constructed to predict OS and DFS using these variables. Discrimination and calibration of the nomogram revealed good predictive abilities (C-index, DFS 0.711; OS 0.702).
CONCLUSION: Independent predictors of recurrence and death following surgery for primary gastric adenocarcinoma were used to create a nomogram to predict DFS and OS. The nomogram was able to stratify patients into prognostic groups, and performed well on internal validation.

Entities:  

Mesh:

Year:  2014        PMID: 25388061     DOI: 10.1245/s10434-014-4230-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  24 in total

1.  Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival.

Authors:  Michela Roberto; Andrea Botticelli; Lidia Strigari; Michele Ghidini; Concetta Elisa Onesti; Margherita Ratti; Ilaria Benzoni; Claudio Pizzo; Rosa Falcone; Daniele Lomiento; Bianca Maria Donida; Luigi Totaro; Federica Mazzuca; Paolo Marchetti
Journal:  Med Oncol       Date:  2018-06-19       Impact factor: 3.064

2.  A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined.

Authors:  Peng-Liang Wang; Fang-Tao Xiao; Bao-Cheng Gong; Fu-Nan Liu; Hui-Mian Xu
Journal:  J Gastrointest Surg       Date:  2017-03-27       Impact factor: 3.452

3.  The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.

Authors:  Jiebin Xie; Yueshan Pang; Xun Li; Xiaoting Wu
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-18       Impact factor: 4.553

4.  Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer.

Authors:  Bujian Pan; Weiteng Zhang; Wenjing Chen; Jingwei Zheng; Xinxin Yang; Jing Sun; Xiangwei Sun; Xiaodong Chen; Xian Shen
Journal:  Front Oncol       Date:  2021-08-09       Impact factor: 6.244

5.  The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.

Authors:  Zi-Xian Wang; Xu-Long Yang; Ming-Ming He; Feng Wang; Dong-Sheng Zhang; Yu-Hong Li; Zhi-Wei Zhou; You-Qing Zhan; Rui-Hua Xu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Authors:  Jing Qian; Yingying Qian; Jian Wang; Bing Gu; Dong Pei; Shaohua He; Fang Zhu; Oluf Dimitri Røe; Jin Xu; Lianke Liu; Yanhong Gu; Renhua Guo; Yongmei Yin; Yongqian Shu; Xiaofeng Chen
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

7.  Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

8.  Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.

Authors:  Xiaowei Sun; Xuechao Liu; Jianjun Liu; Shangxiang Chen; Dazhi Xu; Wei Li; Youqing Zhan; Yuanfang Li; Yingbo Chen; Zhiwei Zhou
Journal:  Chin J Cancer       Date:  2016-06-24

9.  Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy.

Authors:  Jianjun Liu; Qirong Geng; Shangxiang Chen; Xuechao Liu; Pengfei Kong; Zhiwei Zhou; Youqing Zhan; Dazhi Xu
Journal:  Oncotarget       Date:  2016-06-21

10.  Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms.

Authors:  Zi-Xian Wang; Lu-Ping Yang; Miao-Zhen Qiu; Zhi-Qiang Wang; Yi-Xin Zhou; Feng Wang; Dong-Sheng Zhang; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.